文献速递胸部肿瘤

GSTP1基因变异、肺功能、肺癌风险与死亡率的关系

Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality.
PubMed 文献 · J Thorac Oncol · 2017-07-21

在66,069名白人普通人群中,检测GSTP1基因Ile105Val和Ala114Val两个功能性变异,记录肺功能、肺癌、烟草相关癌症和死亡结局。结果显示Ile105Val与肺功能逐级升高、肺癌和烟草相关癌症风险降低及全因死亡率降低相关;Ala114Val与死亡率降低相关,但与肺功能、肺癌或烟草相关癌症无关。

要点

  • GSTP1 Ile105Val与肺功能逐级升高相关(总体p<0.01,吸烟者中p<0.01)。
  • Ile105Val纯合子肺癌风险HR 0.64(0.47-0.89),杂合子HR 0.93(0.78-1.11)。
  • Ile105Val纯合子全因死亡HR 0.87(0.80-0.95),杂合子HR 0.94(0.89-0.99)。

核心结论

  • GSTP1 Ile105Val与普通人群肺功能升高、肺癌和烟草相关癌症风险降低及全因死亡率降低相关。

研究设计与样本

  • 在66,069名白人普通人群中检测GSTP1基因Ile105Val和Ala114Val两个功能性变异,记录肺功能、肺癌、烟草相关癌症和死亡结局。

主要发现

  • 肺功能随Ile105Val基因型逐级升高(总体p<0.01,吸烟者中p<0.01)。
  • 调整后风险比随Ile105Val基因型逐级降低(p<0.02):纯合子 vs 非携带者肺癌HR 0.64(0.47-0.89),杂合子 vs 非携带者HR 0.93(0.78-1.11)。
  • 烟草相关癌症:纯合子 vs 非携带者HR 0.74(0.60-0.92),杂合子 vs 非携带者HR 0.92(0.81-1.04)。
  • 死亡:纯合子 vs 非携带者HR 0.87(0.80-0.95),杂合子 vs 非携带者HR 0.94(0.89-0.99)。
  • Ile105Val纯合子所致肺癌、烟草相关癌症和死亡的人群预防分数分别为4%、3%和2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Glutathione S-transferase pi 1 metabolizes carcinogens from tobacco smoke in the lung. We tested whether genetically altered glutathione S-transferase pi 1 activity affects lung function and risk for tobacco-related cancer and mortality in the general population. METHODS: We genotyped 66,069 individuals from the white general population for two common functional variants in the glutathione S-transferase pi 1 gene (GSTP1)-amino acid isoleucine 105 changed to a valine (Ile105Val) and amino acid alanine 114 changed to a valine (Ala114Val)-and recorded lung function, lung cancer, tobacco-related cancer, and death as outcomes. RESULTS: Lung function was increased stepwise with the Ile105Val genotype overall (p < 0.01) and among smokers separately (p < 0.01). Adjusted hazard ratios for lung cancer, tobacco-related cancer, and death were reduced stepwise with the Ile105Val genotype (p < 0.02): Ile105Val homozygotes and heterozygotes versus noncarriers had hazard ratios for lung cancer of 0.64 (0.47-0.89) and 0.93 (0.78-1.11), for tobacco-related cancer of 0.74 (0.60-0.92) and 0.92 (0.81-1.04), and hazard ratios for death of 0.87 (0.80-0.95) and 0.94 (0.89-0.99), respectively. Population prevented fractions of lung cancer, tobacco-related cancer, and death due to Ile105Val homozygosity were 4%, 3% and 2%, respectively. The Ala114Val genotype was associated with reduced mortality (p < 0.01) but not with lung function, lung cancer, or tobacco-related cancer. CONCLUSION: GSTP1 Ile105Val was associated with increased lung function, reduced risk for lung cancer and tobacco-related cancer, and reduced all-cause mortality in the general population.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Nørskov MS, Dahl M, Tybjærg-Hansen A, et al. Genetic Variation in GSTP1, Lung Function, Risk of Lung Cancer, and Mortality. J Thorac Oncol. 2017. PMID: 28739440. doi:10.1016/j.jtho.2017.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。